Holen Sie sich die Stockscreener-App
5.15
5.33%
-0.29
Handel nachbörslich:
5.15
Schlusskurs vom Vortag:
$5.44
Offen:
$5.21
24-Stunden-Volumen:
48,523
Relative Volume:
1.78
Marktkapitalisierung:
$9.87M
Einnahmen:
$7.88M
Nettoeinkommen (Verlust:
$-69.20M
KGV:
-2.8142
EPS:
-1.83
Netto-Cashflow:
$-69.73M
1W Leistung:
-7.54%
1M Leistung:
-8.85%
6M Leistung:
-48.68%
1J Leistung:
-62.74%
1-Tages-Spanne:
$5.10
$5.451
1-Wochen-Bereich:
$5.10
$5.9771
52-Wochen-Spanne:
$5.10
$14.36
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.15 | 10.43M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Evaluating Bolt Biotherapeutics Inc. with trendline analysis2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Can momentum traders help lift Bolt Biotherapeutics Inc.July 2025 Highlights & Free Verified High Yield Trade Plans - Newser
Bolt Biotherapeutics 2025 Q2 Earnings 59.6% Reduction in Net Loss - AInvest
Intraday pattern recognizer results for Bolt Biotherapeutics Inc.2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Heatmap analysis for Bolt Biotherapeutics Inc. and competitors2025 Price Action Summary & High Return Trade Guides - Newser
Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot - Norwalk Hour
Multi asset correlation models including Bolt Biotherapeutics Inc.Market Volume Report & Expert Curated Trade Setup Alerts - Newser
Is Bolt Biotherapeutics Inc. meeting your algorithmic filter criteriaMarket Risk Analysis & Consistent Profit Trading Strategies - Newser
Can technical indicators confirm Bolt Biotherapeutics Inc.’s reversalQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stockGold Moves & Detailed Earnings Play Alerts - Newser
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates - ca.finance.yahoo.com
Bolt Biotherapeutics: A Case Study in Operational Efficiency and Revenue Upside in Early-Stage Biotech - AInvest
Bolt Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Bolt Bio's New Cancer Drug Enters Clinical Trials as Company Extends Cash Runway Through 2026 - Stock Titan
Long term hold vs stop loss in Bolt Biotherapeutics Inc.July 2025 Catalysts & Verified Momentum Stock Ideas - Newser
Will Bolt Biotherapeutics Inc. bounce back from current supportQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
Key metrics from Bolt Biotherapeutics Inc.’s quarterly data2025 Performance Recap & Entry Point Strategy Guides - Newser
Will earnings trigger a reversal in Bolt Biotherapeutics Inc.M&A Rumor & Long-Term Safe Return Strategies - Newser
Short interest data insights for Bolt Biotherapeutics Inc.Entry Point & High Conviction Buy Zone Picks - Newser
Is Bolt Biotherapeutics Inc. forming a bottoming basePortfolio Value Report & Risk Controlled Swing Alerts - Newser
Predicting Bolt Biotherapeutics Inc. trend using moving averagesFree Short Term Buy List With Stop Protection - Newser
Will breakout in Bolt Biotherapeutics Inc. lead to full recoveryLow Risk Stock Trade Opportunity Analysis - Newser
Using economic indicators to assess Bolt Biotherapeutics Inc. potentialAI Entry Timing Prediction for Swing Traders - Newser
Why Bolt Biotherapeutics Inc. stock attracts strong analyst attentionVolume Based Swing Signal Prediction Map - Newser
Trend analysis for Bolt Biotherapeutics Inc. this weekMarket Liquidity and Price Flow Analysis - Newser
What MACD signals say about Bolt Biotherapeutics Inc.Annual Market Behavior and Sector Summary - Newser
Bolt Biotherapeutics (BOLT) Expected to Announce Earnings on Tuesday - Defense World
Bolt Biotherapeutics BOLT 2025Q2 Earnings Preview Upside Ahead on Promising Clinical Trials - AInvest
Recovery Setup Building in Bolt Biotherapeutics Inc. Experts SayProfit Focused Stock Screener Results Released - beatles.ru
Analyzing Bolt Biotherapeutics Inc. with risk reward ratio chartsEntry Zone Forecast for Momentum Trading - Newser
How Bolt Biotherapeutics Inc. stock performs during market volatilityTechnical Trade Plan with Entry Checklist - Newser
Bolt Biotherapeutics Inc expected to post a loss of $6.45 a shareEarnings Preview - TradingView
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):